Media, PA, United States of America

Allan James Goodman

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Media, PA (US) (2009 - 2013)
  • Wilmington, NC (US) (2014)

Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Allan James Goodman

Introduction

Allan James Goodman is a notable inventor based in Media, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of opioid antagonists. With a total of five patents to his name, Goodman has established himself as a key figure in his area of expertise.

Latest Patents

Goodman's latest patents include innovative compounds that serve as opioid receptor antagonists. These patents focus on certain quinolizidine and octahydropyridopyrazine compounds, along with pharmaceutical compositions and methods of their use. His work aims to provide new solutions in the treatment of opioid-related conditions.

Career Highlights

Throughout his career, Allan James Goodman has worked with prominent companies in the pharmaceutical industry. He has been associated with Adolor Corporation and Merck Sharp & Dohme Corporation, where he contributed to various research and development projects. His expertise has been instrumental in advancing the understanding and treatment of opioid-related issues.

Collaborations

Goodman has collaborated with several notable professionals in his field, including Roland Ellwood Dolle and Bertrand Le Bourdonnec. These collaborations have further enriched his research and innovation efforts.

Conclusion

Allan James Goodman is a distinguished inventor whose work in opioid antagonists has the potential to impact the pharmaceutical industry significantly. His contributions and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…